Cell-based high-throughput screening methods
CA 2451795 A1 · Owner: Nixon, Ralph A. · Inventors: Jiang, Ying; Mathews, Paul M.; Nixon, Ralph A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention describes cell-based screening methods that allows for the elimination of false-positive results due to nonspecific toxicity of test compounds, while detecting those compounds that specifically modulate cellular metabolites in metabolic pathways associated with diseases and disorders. The methods of the invention involved determining within a cell system the levels of both a metabolic precursor and a metabolite of interest that are associated with disease and disease progression with particular regard to Alzheimer's disease.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.